Facile One-Pot Synthesis Methodology for Nitrogen-Containing Heterocyclic Derivatives of 3,5-Disubstituted 4,5-Dihydro-1H-Pyrazole, Their Biological Evaluation and Molecular Docking Studies
- Authors: Upadhyay S.1, Tripathi A.C.1, Paliwal S.2, Saraf S.K.1
- 
							Affiliations: 
							- Faculty of Pharmacy, Babu Banarasi Das Northern India Institute of Technology
- Department of Pharmacy, Banasthali Vidyapith, Banasthali
 
- Issue: Vol 51, No 7 (2017)
- Pages: 564-575
- Section: Article
- URL: https://ogarev-online.ru/0091-150X/article/view/244710
- DOI: https://doi.org/10.1007/s11094-017-1655-7
- ID: 244710
Cite item
Abstract
A series of 2-pyrazoline derivatives (PS-1 to PS-16) were synthesized by reacting different aromatic/heteroaromatic aldehydes and ketones, in a two-step reaction through Claisen – Schmidt condensation, followed by cyclization of the resulting chalcones with hydrazine hydrate in the presence of a base using conventional and microwave approaches. The synthesized derivatives were characterized by various physicochemical methods including IR, 1H-NMR, 13C-NMR, and mass spectroscopic data and elemental analysis. The antidepressant and anti-anxiety activities were evaluated using suitable animal models. Compounds PS-3, and PS-14 showed noticeable antidepressant activity, by reducing the duration of immobility in both tests, while compounds PS-9 and PS-12 were found to possess good anxiolytic activity (by increasing the number of arm entries and open arm exploratory time) at the tested doses (50 and 100 mg/kg b.w.) in comparison to standard drugs imipramine and diazepam, respectively. In order to elucidate binding interactions of the synthesized derivatives to the MAO-A target protein, molecular docking was employed which demonstrated the key interactions with amino acid residues Phe208, Asn181, and Tyr407 at the binding site. Further, the ADME properties of the synthesized derivatives were predicted and found to fall within the stated limits.
About the authors
Savita Upadhyay
Faculty of Pharmacy, Babu Banarasi Das Northern India Institute of Technology
														Email: dirpharmniec@gmail.com
				                					                																			                												                	India, 							Lucknow, U. P., 227105						
Avinash C. Tripathi
Faculty of Pharmacy, Babu Banarasi Das Northern India Institute of Technology
														Email: dirpharmniec@gmail.com
				                					                																			                												                	India, 							Lucknow, U. P., 227105						
Sarvesh Paliwal
Department of Pharmacy, Banasthali Vidyapith, Banasthali
														Email: dirpharmniec@gmail.com
				                					                																			                												                	India, 							Tonk, Rajasthan, 304022						
Shailendra K. Saraf
Faculty of Pharmacy, Babu Banarasi Das Northern India Institute of Technology
							Author for correspondence.
							Email: dirpharmniec@gmail.com
				                					                																			                												                	India, 							Lucknow, U. P., 227105						
Supplementary files
 
				
			 
					 
						 
						 
						 
						 
				 
  
  
  
  
  Email this article
			Email this article  Open Access
		                                Open Access Access granted
						Access granted Subscription Access
		                                		                                        Subscription Access
		                                					